Acetyl-L-Carnitine
Immune Defect
University of CatanzaroDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Immune Defect cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-thioctic acid University of Catanzaro | D | |
Docosahexaenoic Acid University of Catanzaro | D | |
coq10 University of Catanzaro | D |
Same molecule, other indications
Acetyl-L-Carnitine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →